Anthropomorphic Character Animations Versus Digital Chalk Talks in a Resident Diabetes Pharmacotherapy Curriculum: a Randomized Controlled TrialRandomized Controlled Trial Published on 2022-07-012022-10-05 Journal: Journal of General Internal Medicine [Category] 임상, [키워드] activities animation assessments Chalk character Characteristics Controlled COVID-19 pandemic DCT Delayed diabete diabetes Digital Efficacy Factors graduate medical education knowledge mean score medication multimedia. participant pharmacotherapy Qualitative Randomized receive resident resources Science SCS Selection significantly significantly higher statistically significant subgroup analysis suggested survey toolkit was measured [DOI] 10.1007/s11606-022-07510-8 PMC 바로가기 [Article Type] Randomized Controlled Trial
What impact can molnupiravir have on the treatment of SARS-CoV-2 infection?몰누피라비르가 SARS-CoV-2 감염 치료에 어떤 영향을 미칠 수 있습니까?Editorial Published on 2022-06-012022-09-11 Journal: Expert opinion on pharmacotherapy [Category] COVID19(2023년), SARS, 치료제, [키워드] Abstract antivirals coronavirus COVID-19 molnupiravir pharmacotherapy SARS-CoV-2 Treatment [DOI] 10.1080/14656566.2022.2057795 PMC 바로가기 [Article Type] Editorial
Antimalarials for children with Plasmodium vivax infection: Current status, challenges, and research prioritiesarticle Published on 2022-04-302024-09-01 Journal: Parasitology International [Category] 말라리아, [키워드] Artemisinin combination therapy paediatrics pharmacokinetics pharmacotherapy Plasmodium vivax Primaquine, chloroquine, tafenoquine [Article Type] article
The year in cardiovascular medicine 2021: heart failure and cardiomyopathiesArticle Published on 2022-02-032023-07-07 Journal: European heart journal [Category] COVID19(2023년), [키워드] Activators of soluble guanylate cyclase Angiotensin receptor–neprilysin inhibitors artificial intelligence Biomarkers Device therapy Epidemiology heart failure imaging pharmacotherapy SGLT-2 inhibitor. [DOI] 10.1093/eurheartj/ehab887 PMC 바로가기
Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapySARS-CoV-2와 심근세포의 상호작용: 심장 손상 및 약물 요법의 기본 분자 메커니즘에 대한 통찰력Review Published on 2022-02-012022-09-11 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 치료제, [키워드] Abnormalities accessory protein accessory proteins ACE2 adopted advent arteries blood cell calcium cardiac cardiac disease cardiac injuries cardiomyocyte cause CD147 circulating complications Coronary arteries COVID-19 COVID-19 patient dysfunction electrical exhibited Express Extracellular vesicles facilitate heart help homeostasis Infection Injury insight integrin Interaction involved Lungs Manifestations manifested mechanism molecular mechanism pathway Pathways pericyte pericytes pharmacotherapy PROTECT Protein receptor reduced Respiratory illness ROS production SARS-CoV-2 SARS-CoV-2 particle SARS-CoV-2 particles SARS-CoV-2 vaccines severe COVID-19 Side effect Side effects signaling pathway Spectrum subject Support the SARS-CoV-2 TMPRSS2 Treatment Vaccine virus [DOI] 10.1016/j.biopha.2021.112518 PMC 바로가기 [Article Type] Review
Immediate smoking cessation support versus usual care in smokers attending a targeted lung health check: the QuLIT trial대상 폐 건강 검진에 참석하는 흡연자의 일반적인 치료와 비교하여 즉각적인 금연 지원: QuLIT 시험Randomized Controlled Trial Published on 2022-02-012022-09-11 Journal: BMJ Open Respiratory Research [Category] COVID19(2023년), SARS, 임상, 치료기술, 치료제, [키워드] Anxiety approach Cancer Cancer screening check conducted COVID-19 pandemic CT scan CT scans desire Effectiveness female Health imaging/CT MRI etc Immediate increase increase in intervention group investigated lung lung cancer material MRI offer offered outcome participant performed pharmacotherapy Primary outcome randomised controlled trial Randomly registration number Research responses single-blind smoker Smokers smoking smoking cessation Stress Support thematic analysis Tobacco tobacco and the lung. Trial usual care [DOI] 10.1136/bmjresp-2021-001030 PMC 바로가기 [Article Type] Randomized Controlled Trial
Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases염증성 질환에서 하이드 록시 클로로 퀴인 및 아지트로 마이신과의 인터루킨 -6 조합의 부정맥 메커니즘Article Published on 2022-01-202022-09-01 Journal: Scientific Reports [Category] 진단, 치료제, [키워드] Abnormalities abnormality action potential addition Administered analyzed arrhythmia Arrhythmias asystole Azithromycin bradycardia cardiac injury Cardiology caused characterized Combination COVID-19 Critical cytokine Cytokine storm disease drug drug combination Drug discovery Electrocardiograms electrocardiographic elevated examined greater HCQ heart rate Hydroxychloroquine IL-6 IL-6 receptor immunology In-vitro Inflammation inflammatory disease Inflammatory diseases Injury interleukin-6 management mechanism Medical research Mild mild to moderate moderate monoclonal antibody pharmacotherapy Physiology PIGS prolongation QTc QTC prolongation reducing reduction in risk selective selective inhibition TCZ therapy Tocilizumab [DOI] 10.1038/s41598-022-04852-5 PMC 바로가기 [Article Type] Article
COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and PharmacotherapyEndocrinology Published on 2021-11-192022-10-31 Journal: Frontiers in Endocrinology [Category] COVID-19, MERS, SARS, [키워드] ACE2 ACE2 (angiotensin converting enzyme 2) angiotensin Anticoagulants CD147 Clinical management comorbid patient Comprehensive COVID - 19 COVID-19 COVID-19 susceptibility DC-SIGN diabete Diabetes Mellitus diabetic patient DPP4 drugs Effect Efficacy evaluated form Gender glucocorticoid implication inhibitors Interaction knowledge L-SIGN mACE2 patients with COVID-19 Perspective pharmacotherapy positive receptor review risk sACE2 SARS- CoV-2 SARS-COV-2 infection severity surface receptor therapeutic management Treatment viral cell [DOI] 10.3389/fendo.2021.772865 PMC 바로가기 [Article Type] Endocrinology
Herb-Drug Interaction Between Xiyanping Injection and Lopinavir/Ritonavir, Two Agents Used in COVID-19 PharmacotherapyPharmacology Published on 2021-11-112022-10-31 Journal: Frontiers in Pharmacology [Category] COVID-19, [키워드] administration Affect agent approach AUC benefit changed clinical setting clinician Combination coronavirus disease Coronavirus disease 2019 COVID-19 CYP3A4 death decrease demonstrated dose drugs effective Epidemic exhibit exhibited expression herb-drug interactions human liver in vitro in vivo inhibited inhibiting injection Interaction intravenous dose lack Lopinavir/ritonavir LPV outbreak parameter Patient pharmacokinetic pharmacotherapy Precaution Protein risk RTV Seven significantly TCM Traditional Chinese medicine Treatment xiyanping injection [DOI] 10.3389/fphar.2021.773126 PMC 바로가기 [Article Type] Pharmacology
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines사용 가능한 COVID-19 백신의 기술, 메커니즘, 안전성 및 효능에 대한 집중 검토Review Published on 2021-11-012022-09-11 Journal: International immunopharmacology [Category] MERS, SARS, 변종, 진단, 치료기술, [키워드] Accessibility adenovirus-based Adverse reaction Adverse reactions approval approved caused China Clinical data country Coverage COVID-19 COVID-19 infection COVID-19 vaccine COVID-19 vaccines disadvantage Disadvantages dosage Efficacy Health Health Organizations Inactivated vaccine Inactivated Vaccines Infection intervals introduced lack management mechanisms moderate to severe morbidity morbidity and mortality Novel coronavirus nucleic acid Nucleic acid-based vaccines organizations pandemic patients with moderate pharmacotherapy platform prevention Protein-based vaccines remained SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants severe COVID-19 Spread Stage storage the disease therapeutic option underlying disease underlying diseases vaccination Vaccine vaccine platform Vaccines Viral Viral vector vaccines Wuhan [DOI] 10.1016/j.intimp.2021.108162 PMC 바로가기 [Article Type] Review